Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Docebo Inc. Announces Substantial Issuer Bid, Preliminary Unaudited Fourth Quarter 2025 Financial Results and 2026 Guidance
-
Canaccord Genuity Starts LightPath Technologies (LPTH) at Buy
-
Form 8.3 - [MIND GYM PLC - Opening Disclosure - 28 01 2026] - (CGAML)
-
Form 8.3 - [IQE PLC - 28 01 2026] - (CGAML)
-
Form 8.3 - [IDOX PLC - 28 01 2026] - (CGWL)
-
Canaccord Genuity Starts SharpLink Gaming (SBET) at Buy
-
Tesla (TSLA) PT Lowered to $520 at Canaccord Genuity
-
Joby Aviation prices $600 million convertible notes and stock offering
-
Joby Aviation Prices Upsized Offering of Primary Common Stock and Upsized Offering of Convertible Senior Notes
-
Canaccord Genuity Starts Downer EDI Ltd (DOW:AU) (DNERF) at Buy
-
Meta Platforms Inc. (META) PT Raised to $930 at Canaccord Genuity
-
A$40 Million Institutional Placement to Support 30% Expansion of Phase 1 Hombre Muerto West (HMW)
-
York Space Systems Announces Pricing of Upsized Initial Public Offering
-
MRF 2026 Resource Limited Partnership Closing February 26, 2026 – Maximum $75,000,000
-
Maple Leaf Critical Minerals 2026 Enhanced Flow-Through Limited Partnership NATIONAL & QUEBEC CLASS Series A and Series F
-
Transaction in Own Shares
-
AEA Elevate Partners with 829 Studios
-
Zodiac Gold Announces Closing of Upsized LIFE Offering for Gross Proceeds of $6.1 Million
-
PPHC prices US IPO at $12.25 per share, raising $50.8 million
-
PPHC Announces Nasdaq Listing and Pricing of U.S. Initial Public Offering
-
Form 8.3 - [IDOX PLC - 27 01 2026] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Stride Inc. (LRN)
-
INTURAI VENTURES SELECTS CANACCORD AND ENTERS INTO STRATEGIC ADVISORY AGREEMENT PRIOR TO NORTH AMERICAN ROADSHOW
-
Arrow Announces Appraisal Well M-8 Results
-
Arbe Robotics closes $18.5 million stock offering
-
Arbe Robotics, Ltd. Announces Closing of $18.5 Million Underwritten Registered Direct Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
-
Form 8.3 - [IDOX PLC - 26 01 2026] - (CGWL)
-
IsoEnergy Completes C$57.5 Million Bought Deal Financing
-
Ascot Resources closes C$175 million private placement, names new chair
-
Ascot Announces Closing of the Final Tranche of Private Placement, Raising Aggregate Gross Proceeds of C$175 Million and Appoints Alex Morrison as Chair of the Board of Directors
-
Summize Raises $50 Million to Accelerate Global Expansion and Advance AI Contract Intelligence
-
USA Rare Earth Inc (USAR) PT Raised to $33 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
-
Net Asset Value(s)
-
Empire Metals Limited Announces Pitfield Project Development Update
-
Golden Rapture Mining Closes Final Tranche of Non-Brokered Private Placement
-
Sprott Physical Uranium Trust Updates Its “At-the-Market” Equity Program
-
Form 8.3 - [IQE PLC - 23 01 2026] - (CGAML)
-
Arbe Robotics prices $16 million share offering at $1.40 per share
-
Arbe Robotics Ltd. Announces $16 million Underwritten Registered Direct Offering
-
Terra Innovatum Global to Participate at Upcoming Investor & Industry Conferences
-
Terra Innovatum Global to Participate at Upcoming Investor & Industry Conferences
-
Canaccord Genuity Reiterates Hold Rating on Caris Life Sciences Inc (CAI)
-
Canaccord Genuity Reiterates Buy Rating on Guardant Health (GH)
-
Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)
-
Canaccord Genuity Reiterates Buy Rating on Pacific Biosciences of California (PACB)
-
Illumina (ILMN) PT Raised to $150 at Canaccord Genuity
-
Canaccord Genuity Downgrades Lifetime Brands (LCUT) to Hold
-
Publication of an Offer Document and Relevant Related Party Transaction
-
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

